TIL Therapy for Advanced Skin Cancer Patients
Treatments studied
Part of Cancer, Infections, Skin clinical trials.
This study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced skin cancers that have not responded to immunotherapy. Doctors take your tumor cells, grow immune cells from them, and then infuse them back to fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of skin cancer called cutaneous squamous cell carcinoma or Merkel cell carcinoma that has spread or come back.
- Your cancer must have gotten worse after trying immunotherapy drugs like Keytruda or Opdivo.
- You need at least one tumor that is large enough (about half an inch) for doctors to remove and make into a personalized cell treatment.
- You should be generally up and about and able to take care of yourself (ECOG score 0-2).
- Your heart, lungs, and blood counts must be in good enough shape to handle the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called tumor-infiltrating lymphocyte (TIL) therapy for people with advanced melanoma that has not responded to immune checkpoint inhibitors. TIL therapy uses your own immune cells to fight the cancer. The study aims to see if this can help shrink tumors or slow the disease.
This trial tests a new treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer. The cells are taken from a tumor, multiplied in a lab, and given back to you to help your body attack the cancer.
This trial tests a new cell therapy that uses your own immune cells (TILs) to fight lung cancer. If you have advanced non-small cell lung cancer and standard treatments haven't worked, this treatment might help your immune system attack the cancer more effectively.
This trial tests a new T-cell therapy made from your own tumor (TILs), genetically edited to remove the PD1 checkpoint blocker. It may help your immune system fight melanoma that has not responded to standard treatments like anti-PD1 therapy.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
Hear when a new Cutaneous Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.